The volume-duration relationship using low concentrations of ropivacaine for peripheral nerve blocks is unknown, even though low concentrations of ropivacaine are increasingly used clinically. We investigated the effect of ropivacaine 0.2% on common peroneal nerve block duration. With ethical committee approval, 60 consenting, healthy volunteers were randomly allocated to receive one of five volumes of ropivacaine 0.2% (2.5, 5.0, 10, 15 or 20 ml) administered by ultrasound-guided, catheter-based injection (at 10 ml.min À1 ) near the common peroneal nerve. Our primary outcome was duration of sensory block, defined by insensitivity to a cold stimulus. Our secondary outcome was duration of motor block. Outcomes were assessed every hour from onset of block to complete remission. Intergroup differences were tested using one-way ANOVA followed by regression analyses using the 20 ml intervention group as reference. Block durations varied significantly (p < 0.0001) between groups. Mean (SD) sensory block durations were 9.2 (3.3), 12.5 (3.0), 15.5 (4.4), 17.3 (3.5) and 17.3 (4.6) h. Mean (SD) motor block durations were 3.3 (2.1), 7.2 (2.5), 9.2 (2.2), 12.7 (2.5) and 12.5 (2.5) h. Regression analysis showed that the effect of volume on block duration was progressively smaller with increasing volume, reaching a threshold volume above which there was no effect on nerve block duration (10 ml for sensory block and 15 ml for motor block). We conclude that there is a ceiling effect of increasing volume of ropivacaine 0.2% on both sensory and motor block duration of the common peroneal nerve.
Introduction
Successful peripheral nerve block depends on the technical skills of the anaesthetist and the type and dose (volume and concentration) of administered local anaesthetic (LA) [1] [2] [3] [4] [5] [6] .
Assuming a fixed LA concentration, the benefits of increasing LA volume in order to provide a faster onset, denser and longer-lasting nerve block must be balanced against the risk of LA systemic toxicity. With advances in ultrasound-(US) guided techniques it has been possible to reduce the LA volume required to perform a successful nerve block [7] [8] [9] [10] , which has reduced the risk of systemic toxicity [11] [12] [13] . However, low LA volumes seem to shorten nerve block duration [8, 14, 15] , although results are conflicting [16, 17] . Several investigators have proposed the possibility of a LA dose-response ceiling effect on nerve block duration [15, 17, 18] , but previous dose ranging trials show large variations in block durations [8, [15] [16] [17] , report high failure rates when using small doses of LA [15, 17] , or report inconsistent data on nerve block remission [18, 19] .
Confounding factors relate to long intervals of testing [15] , anatomic variation when assessing block of multiple nerves [15, 16] , patient-reported outcomes [15, 19] , and supplemental nerve blocks that might alter the clearance of LA (and nerve block duration) [15, 17] . Furthermore, LAs in low concentrations are increasingly being used for peripheral nerve blocks, but knowledge on the doseduration relationship for these is sparse.
We designed a randomised, double-blind cohort trial to investigate the relationship between LA volume and peripheral nerve block duration using a fixed and low LA concentration. We involved healthy volunteers, a constant LA infusion rate with an electronic infusion pump through a peripheral nerve catheter and investigator-assessed, standardised outcome measures at 1-h intervals. We investigated the common peroneal nerve because it has a well-defined cutaneous innervation area, and alone innervates the muscles causing dorsiflexion of the foot. We hypothesised that increased volumes of ropivacaine 0.2% would prolong nerve block duration, but there would be a dose-response ceiling effect. We also hypothesised that nerve block duration variation would decrease with increasing LA volume. Our primary outcome was duration of sensory block, defined as insensitivity towards cold. An independent observer accompanied the project nurse and verified that infusions complied with the protocol.
Methods
Participants and outcome assessors were blinded to infusion procedures. To ensure blinding during LA infusions, outcome assessors were not in the room and infusion pumps were turned away from the participants.
Our primary outcome was the duration of sensory block. Our secondary outcome was the duration of motor block. Explorative outcomes were onset times, degrees of sensory and motor block and adverse events. Outcomes were assessed by a member of the investigator team.
Members were thoroughly trained using standardised question-answer rhetoric. For exploration of adverse events, the primary investigator made post-trial calls 2 weeks after study day.
A round, cooled glass vial was applied on the lateral part of the lower leg using the contralateral leg as reference.
The cooled glass vial was stored in a refrigerator (5°C) until The minimal relevant effective difference in nerve block duration was considered to be 3 h. Mean (SD) sensory block duration for 5 ml of ropivacaine 0.2% was assumed to be 14 (2.5) h [15] [16] [23] [24] [25] [26] [27] . We estimated the dropout rate to be one subject per trial group. Sample size was calculated using a significance level of 5% and a power of 80%. We therefore planned 12 participants per group for each of the five intervention groups. Consequently, 60 participants were needed for the entire trial.
Results
All included volunteers completed the trial (Fig. 1 ).
Participant characteristics and study outcomes are described in Tables 1 and 2 , respectively. All 60 participants had sensory block of the common peroneal nerve, and 54/60 had motor block.
There was a significant difference in sensory nerve block duration between groups (p < 0.0001). Similarly, we found a significant difference in motor nerve block duration between groups (p < 0.0001). Regression analyses demonstrated a positive effect of LA volume on both sensory and motor block duration (Table 3 ). However, the incremental effect declined with increasing volume. We observed no increase in sensory block duration above 10 ml of ropivacaine and no increase in motor block duration above 15 ml of ropivacaine. The variation in both sensory and motor block duration was large and did not change with increasing volume.
There was a significant difference in the duration of anaesthesia (sensory block grade 4 = no sensation) between groups (p < 0.0001). The prolongation of anaesthesia was progressively smaller with increasing volume with a threshold volume of 10 ml (Table 4 ).
The duration of paralysis (motor block grade 3) also differed significantly between groups (p < 0.0001).
Regression analysis showed a prolongation of paralysis with increasing volume of LA. There was no significant difference between the groups receiving 15 and 20 ml (Table 4) .
No adverse events were recorded, and no participants had signs of neurological injury at the post-trial phone call.
Discussion
The purpose of this trial was to explore the volume-duration relationship between ropivacaine 0.2% and peripheral nerve block. As hypothesised, we observed prolonged sensory and motor block durations with increasing LA volume. More importantly, we found that the incremental effect on nerve block duration was progressively smaller with increasing LA volume, reaching a threshold volume above which there was no significant difference in block duration, i.e. a ceiling effect. This was observed for both sensory and motor block durations, as well as for the A ceiling effect and LA volume threshold for nerve block duration have been proposed before [15, 18] .
However, these studies lacked data on nerve block remission [18] and had high failure rates in patients receiving low LA volumes [15] . Nader et al. found a threshold volume for both ropivacaine and bupivacaine 0.5% with adrenaline after infragluteal sciatic nerve block in patients undergoing total knee arthroplasty [15] . They reported large variations in block durations, which may have resulted from several confounding factors. Patients Table 1 Baseline characteristics of 60 volunteers who received common peroneal nerve block. Values are mean (SD) or number.
2.5 ml n = 12 5.0 ml n = 12 10 ml n = 12 15 ml n = 12 20 ml n = 12
Age; y 23 (5) 24 (3) 23 (3) 26 (10) 25 (8) Male; n 6 5 4 9 4
Height; cm 179 (13) 176 (8) 174 (12) 182 (11) 171 (8) Weight; kg 70 (10) 70 (12) 69 (13) 78 (8) 66 (12) BMI; kg.m
À2
22 (2) 23 (3) 23 (4) 24 (4) 23 (3) BMI, body mass index. Table 3 Regression analysis of sensory and motor block duration. Participants not experiencing motor block were excluded. B values represent block durations in hours compared with the 20 ml reference volume (Group 5). B values of the corresponding volumes (2.5 ml to 15 ml) represent changes in duration (h).
2.5 ml 5.0 ml 10 ml 15 ml 20 ml
Duration of sensory block; h.ml Duration of motor block; h
Duration of motor block; h.ml We accept that the durations of nerve block we measured are not necessarily transferrable to clinical practice. Although loss of cold sensation shows better sensitivity and specificity compared with other tests of sensory nerve block [17] , it is physiologically and subjectively different to a painful surgical stimulus. Our subjective assessment of motor block also lacked objectivity.
The volume-duration relationship found in our trial shows that, per ml, small volumes of ropivacaine 0.2% result in two and four times the duration of motor and sensory block duration, respectively. This is useful to know when designing and investigating low-dose LA bolus regimens for catheter-based nerve blocks. Our results also show an increasing proportion of participants with paresis and paralysis, and duration of the latter, with increasing LA volume, which is important to know when providing peripheral nerve blocks for postoperative analgesia. Not only should these nerve blocks be safe and effective, but also with a minimum of motor impairment.
Large variations in nerve block duration have been reported previously [15-17, 19, 23-26] . The common belief that simply administering more LA will ensure prolonged block duration may not be true, and identifying factors that could decrease this variation is important. Furthermore, whether variation occurs predominantly between individuals, or in the same individual (or both) needs further investigation.
Similarly, as LA volume increased, LA dose increased, and further work is needed to determine whether our findings relate more to injected volume or to the dose of ropivacaine administered.
In conclusion, we found a ceiling effect of increasing volume of ropivacaine 0.2% on both sensory and motor block duration of the common peroneal nerve. We observed large variations in block duration, which did not decrease with increasing LA volume. 
